Akamara Therapeutics is a startup.
Akamara Therapeutics is a startup.
Akamara Therapeutics is a biotechnology company developing supramolecular structures for B-cell immunotherapy, with a lead molecule targeting triple negative breast cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.